Harbin Gloria Pharmaceuticals Co (SZSE:002437) Other Long-Term Liabilities : ¥32 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Harbin Gloria Pharmaceuticals Co Other Long-Term Liabilities?

Harbin Gloria Pharmaceuticals Co's other long-term liabilities for the quarter that ended in Mar. 2024 was ¥32 Mil.

Harbin Gloria Pharmaceuticals Co's quarterly other long-term liabilities declined from Sep. 2023 (¥31 Mil) to Dec. 2023 (¥30 Mil) but then increased from Dec. 2023 (¥30 Mil) to Mar. 2024 (¥32 Mil).

Harbin Gloria Pharmaceuticals Co's annual other long-term liabilities declined from Dec. 2021 (¥38 Mil) to Dec. 2022 (¥34 Mil) and declined from Dec. 2022 (¥34 Mil) to Dec. 2023 (¥30 Mil).

Harbin Gloria Pharmaceuticals Co Other Long-Term Liabilities Historical Data

The historical data trend for Harbin Gloria Pharmaceuticals Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Gloria Pharmaceuticals Co Other Long-Term Liabilities Chart

Harbin Gloria Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Harbin Gloria Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Harbin Gloria Pharmaceuticals Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Harbin Gloria Pharmaceuticals Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Harbin Gloria Pharmaceuticals Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

N/A

Address

Beijing Road No 29, Harbin Economic and Technological Development Zone, Harbin, CHN, 150025

Website

http://www.gloria.cc

Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.

Executives

Guo Yun Pei	Independent director
Wang Yu	Supervisors
Yang Hong Bing	Director
Diao Xiu Qiang	Directors, executives
Liu Yue Yin	Securities Affairs Representative
Guo Lei Feng	Directors, Directors, and Executives
Li Jun Ling	Director
Yang Hai Feng	Executives
Zhang Su Mei	Supervisors
Zhu Ji Man	Director

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Headlines

No Headlines